Day: April 17, 2021

NEWPORT NEWS, Va., April 17, 2021 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE:HII) hosted commencement exercises on Saturday for 154 graduates of the company’s Apprentice School at Newport News Shipbuilding. Due to the COVID-19 environment, and in an effort to keep all employees, staff, graduates and their guests safe, the ceremony was held outdoors at the Hampton Roads Convention Center in Hampton. “A drive-in movie-style graduation is likely not what you expected, but I think it’s pretty safe to say that the past year in many ways isn’t what any of us expected,” said Jennifer Boykin, president of Newport News Shipbuilding. “Graduating from The Apprentice School is not an easy feat and when you couple the long hours balancing your work and your studies, along with new obstacles you faced this year, like remote learning...

London, April 17, 2021 CNH Industrial confirms that it is has terminated discussions with FAW Jiefang with regard to the Company’s On-Highway business, and is continuing to pursue its existing plans for a spin-off of these activities in early 2022. CNH Industrial believes there are significant opportunities to develop its On-Highway business by accelerating the deployment of ever more sustainable transport solutions and infrastructure, in line with the EU’s Green Deal ambitions. CNH Industrial N.V. (NYSE: CNHI /MI: CNHI) is a global leader in the capital goods sector with established industrial experience, a wide range of products and a worldwide presence. Each of the individual brands belonging to the Company is a major international force in its specific industrial sector: Case IH, New Holland Agriculture and Steyr for tractors and...

Study quantified coronary plaque changes in patients administered 4 g/day of VASCEPA® (icosapent ethyl) on top of statin therapy Effect on coronary plaque stabilization reported to be significant at 9 months and sustained at 18 months DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that further analyses from the Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides on Statin Therapy: EVAPORATE Trial were presented as Late-Breaking Science at European Society of Cardiology (ESC) Preventive Cardiology 2021, the Annual Congress of the European Association of Preventive Cardiology, on April 17, 2021, 3:50 PM CEST (Central European Summer Time) by Andrew Buckler, Founder and CTO of Elucid. As previously...

Í 15. viku 2021 keypti VÍS 10.000.000 eigin hluti fyrir kr. 162.950.000 eins og hér segir:Vika Dagsetning Tími  Keyptir hlutir Viðskiptaverð  Kaupverð  Eigin hlutir eftir viðskipti15 12.4.2021 10:08               2.000.000 15,90    31.800.000       20.000.00015 13.4.2021 09:59               1.000.000 15,90    15.900.000       21.000.00015 13.4.2021 14:05               1.000.000 16,25    16.250.000       22.000.00015 14.4.2021 09:34               2.000.000 16,40    32.800.000       24.000.00015 15.4.2021 09:38               2.000.000 16,50    33.000.000       26.000.00015 16.4.2021 09:32               2.000.000 16,60    33.200.000       28.000.000Samtals                 10.000.000    162.950.000       28.000.000Þessi kaup eru í samræmi við endurkaupaáætlun félagsins á eigin hlutum sem hrint var í framkvæmd 9....

Secondary endpoint data for once-nightly FT218 further supports previously announced topline data demonstrating clinically meaningful results at 6 g, 7.5 g, and 9 g dosesDUBLIN, Ireland, April 17, 2021 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate (ON-SXB) for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy, today announced the presentation of positive secondary endpoint data at the 2021 American Academy of Neurology Annual (AAN) Meeting being held virtually from April 17-22, 2021. FT218 is currently under review at the U.S. Food and Drug Administration with a Prescription Drug User Fee Act (PDUFA) target date of October 15, 2021. “The positive results previously disclosed...

VANCOUVER, British Columbia, April 16, 2021 (GLOBE NEWSWIRE) — Ultra Resources Inc. (TSX-V: ULT) (“Ultra Resources” or the “Company”) further to the Company’s April 7, 2021 and April 8, 2021 news releases that it has closed a non-brokered private placement the Company corrects the private placement to 10,892,900 units at $0.11 per unit for total gross proceeds of $1,198,219. Each Unit is comprised of one common share and one-half non-transferable common share purchase warrant (“Warrant”). Each whole Warrant will entitle the holder to purchase an additional common share of the Company at an exercise price of $0.20 per share for a period of one year from closing of the private placement provided that if the closing price of the common shares of the Company on any stock exchange or quotation system on which the common shares...

VANCOUVER, British Columbia, April 16, 2021 (GLOBE NEWSWIRE) — (CSE: MOJ) (OTCBB: MOJGF) (“Mojave” or the “Company”) wishes to announce that it will not be proceeding with the non-brokered private placement of up to 6,000,000 units of the Company at a price of $0.50 per unit for a total of CA $3.0 million that was announced on March 8, 2021. On behalf of the Board of Directors “Cole McClay”, CEO Mojave Gold Corp. info@Mojavegoldcorp.com www.mojavegoldcorp.com Forward Looking Statements Certain of the statements made and information contained herein may contain forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking information includes, but is not limited to, information concerning the Company’s intentions with respect to the development of its mineral properties. Forward-looking...

TORONTO, April 16, 2021 (GLOBE NEWSWIRE) — O2Gold Inc. (“O2Gold” or the “Company”) (TSXV: OTGO) is pleased to announce that it has closed its previously announced non-brokered private placement financing (the “Offering”). The Company issued 17,390,000 units (each, a “Unit”) at a price of $0.20 per Unit for gross proceeds of $3,478,000. For more information on the Offering, please see the Company’s press releases dated January 14, 2021 and March 22, 2021, which are available under the Company’s profile on SEDAR at www.sedar.com. Pursuant to the Offering, each Unit consists of one common share of the Company (each, a “Common Share”) and one-half of one Common Share purchase warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder to acquire one additional Common Share at an exercise price of $0.30 at any time prior...

VANCOUVER, British Columbia and TORONTO, April 16, 2021 (GLOBE NEWSWIRE) — Clean Power Capital Corp. (CSE: MOVE)(FWB: 2K6)(OTC: MOTNF) (“Clean Power” or the “Company” or “MOVE”) is pleased to announce that it has submitted an initial application to list its common shares (the “Common Shares”) on the NASDAQ Capital Market (“Nasdaq”). The Company previously announced on December 3, 2020 that the Board of the Company had formed a strategic committee to review and develop a strategy to enhance its investor profile through a capital markets strategy focused on the United States. As part of the review, the strategic committee would consider an application to list its common shares on Nasdaq. Upon consultation with advisors and legal counsel, the Company submitted its initial application to list its Common Shares on Nasdaq....

VANCOUVER, British Columbia, April 16, 2021 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) (“Monument” or the “Company”) announces it has granted an aggregate of 3.9 million restricted share units (the “RSUs”) to its directors, officers and employees pursuant to the RSU plan. The Company’s RSU and stock based option plans are aimed to compensate and reward its directors, officers and employees for working towards the Company’s long term objectives and in alignment with the shareholders’ best interest. Out of 3.9 million newly granted RSUs, 1.1 million is granted as a part of the director’s fee restructure where the cash component has been significantly reduced; 1.7 million are performance RSUs rewarding their milestone achievement upon closing of the Mengapur transaction; and 1.1 million are granted to incentivize...